Topic Review
Immunomodulatory Activity of Antimicrobial Peptides
Antimicrobial peptides (AMPs) in humans are represented by three main families: defensins, cathelicidins, histatins. Defensins, depending on the type of disulfide bond arrangement, are divided into alpha- and beta-defensins. Alpha- and beta-defensins are constitutively produced by neutrophils, lymphocytes, and epithelial cells of the skin and mucous membranes.
  • 521
  • 18 Mar 2022
Topic Review
Pregnancy and Vaccination during COVID-19 Pandemic
Pregnancy, alone, being associated with a state of immune alterations, exposes the maternal immune system to many challenges. Pregnant women, being a highly vulnerable group, need to be administered vaccines as early as possible; however, there is a lot of vaccine hesitancy among the population regarding immunization of pregnant women, who are avoided in the initial phases of most clinical trials. A look at available studies on the mechanisms of immune response in pregnant women and further, the reports of vaccine efficacy and outcomes among pregnant women against COVID-19 and EVD would definitely yield many insights that could be useful in the surveillance and planning of vaccination strategies for pregnant women against impending pathogenic RNA viruses.
  • 521
  • 27 Jul 2022
Topic Review
Clinical Strategies of CAR-T-Cell Therapy for Hematological Malignancies
Chimeric antigen receptor (CAR) T cells have been successfully used for hematological malignancies, especially for relapsed/refractory B-cell acute lymphoblastic leukemia and non-Hodgkin's lymphoma. Patients who have undergone conventional chemo-immunotherapy and have relapsed can achieve complete remission for several months with the infusion of CAR T-cells. However, side effects and short duration of response are still major barriers to further CAR T-cell therapy. To improve the efficacy, multiple targets, the discovery of new target antigens, and CAR T-cell optimization have been extensively studied.
  • 521
  • 14 Oct 2022
Topic Review
FcRn for Biologics' Nasal Delivery
It was registered on the international prospective register of systematic reviews PROSPERO, which helped in identifying articles that met the inclusion criteria. Clinical and preclinical studies involving FcRn and the nasal delivery of biologics were screened, and the risk of bias was assessed across studies using the Oral Health Assessment Tool (OHAT). Among the 12 studies finally included in this systematic review (out of the 758 studies screened), 11 demonstrated efficient transcytosis of biologics through the nasal epithelium.
  • 518
  • 30 Jun 2021
Topic Review
From Stem Cells to Immune Cells Populations
Although stem cells have been considered promising for the treatment of degenerative diseases by ‘seeding’ them into damaged tissues, it has recently been observed that the regenerative capacity of stem cells is influenced and regulated by the local immune response and in particular by macrophages, which constitute a central component of the damage response and are the coordinators of tissue repair and regeneration. Among the panoply of immune cells involved in the response to both acute and chronic wounds, recent discoveries have highlighted novel and often unexpected roles for certain types of immune cells in promoting a permissive local environment for effective cell replacement and restoration of tissue integrity. Some studies have shown that the control of inflammation is crucial in regenerative therapies: To be effective, regenerative therapies must block and control inflammation to allow tissue regeneration by resident stem cells. Indeed, the presence of inflammation inhibits the regenerative action of tissue-resident mesenchymal stem cells (MSCs). Recent papers suggest that an innovative regenerative strategy could be to polarize macrophages from the M1 inflammatory state to the M2 anti-inflammatory state utilizing immune cells. These reviews conclude that next-generation regenerative therapies need an immune-centric approach instead of the use of stem cells. Thus, depending on the tissue or organ targeted, regenerative strategies could be developed to stimulate macrophage polarization or to recruit subpopulations of pro-healing macrophages. Already, it has been observed  that the regeneration of myocardial tissue after ischemia was induced by macrophages that regulate resident stem cells and promote regeneration, suggesting that targeting macrophages could be a new strategy to improve infarct healing and repair. The regenerative and stem-cell-controlling capacity of macrophages has also recently been demonstrated in bone tissue: mesenchymal stem cells act through a paracrine and immune-modulatory and non-differentiative mechanism and the microenvironment and immune system regulate the activity of MSCs regardless of the tissue from which they originate. Based on the role played by several types of macrophages and lymphocytes in the wound-healing response, it is tempting to hypothesize that interventions that reduce the M1 macrophage phenotype and promote M2 may represent a new therapy to induce tissue regeneration.
  • 518
  • 28 Feb 2022
Topic Review
Immune Response to SARS-CoV-2 Vaccines
COVID-19 vaccines have been developed to confer immunity against the SARS-CoV-2 infection. Prior to the pandemic of COVID-19 which started in March 2020, there was a well-established understanding about the structure and pathogenesis of previously known Coronaviruses from the SARS and MERS outbreaks. In addition to this, vaccines for various Coronaviruses were available for veterinary use. This knowledge supported the creation of various vaccine platforms for SARS-CoV-2. Before COVID-19 there are no reports of a vaccine being developed in under a year and no vaccine for preventing coronavirus infection in humans had ever been developed. Approximately nine different technologies are being researched and developed at various levels in order to design an effective COVID-19 vaccine. As the spike protein of SARS-CoV-2 is responsible for generating substantial adaptive immune response, mostly all the vaccine candidates have been targeting the whole spike protein or epitopes of spike protein as a vaccine candidate.
  • 518
  • 13 Jul 2022
Topic Review
Neutrophils and Angiogenesis in Cancer
Tumor angiogenesis is one of the most critical steps in the progression of cancer. Owing to its fundamental role in tumor growth and metastasis, tumor angiogenesis is accepted to be a limiting factor and considered a powerful therapeutic target. Neutrophils contribute to the tumor progression via multiple mechanisms, ranging from the direct support of tumor cell survival to the immunosuppression. A strong body of evidence suggests that neutrophils also play a prominent role in tumor angiogenesis.
  • 517
  • 29 Mar 2022
Topic Review
Mitochondrial Dysfunction Involved in the Pathogenesis of ALS
Amyotrophic lateral sclerosis (ALS) is an incurable neurodegenerative disease, the pathogenesis of which is based on alternations in the mitochondria of motor neurons, causing their progressive death. A growing body of evidence shows that more efficient mitophagy could prevent and/or treat this disorder by suppressing mitochondrial dysfunction-induced oxidative stress and inflammation. Mitophagy has been considered one of the main mechanisms responsible for mitochondrial quality control.
  • 515
  • 22 Dec 2022
Topic Review
Gold Organs in Brucellosis
Brucella is an intracellular bacterium that causes abortion, reproduction failure in livestock and leads to a debilitating flu-like illness with serious chronic complications if untreated in humans. The “gold organs” for nesting Brucella, in which Brucella replicates in cells of the reticular endothelial system, include the spleen, lymph nodes, liver, bone marrow, epididymis, and placenta.
  • 514
  • 19 May 2023
Topic Review
Extracellular Vesicles and Sepsis
Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to an infection. Several studies on mouse and patient sepsis samples have revealed that the level of extracellular vesicles (EVs) in the blood is altered compared to healthy controls, but the different functions of EVs during sepsis pathology are not yet completely understood. Sepsis EVs are described as modulators of inflammation, lymphocyte apoptosis, coagulation and organ dysfunction. Furthermore, EVs can influence clinical outcome and it is suggested that EVs can predict survival. Both detrimental and beneficial roles for EVs have been described in sepsis, depending on the EV cellular source and the disease phase during which the EVs are studied.
  • 513
  • 17 Sep 2021
Topic Review
Therapeutic Targeting of Tumor Collagen
The tumor stroma, which comprises stromal cells and non-cellular elements, is a critical component of the tumor microenvironment (TME). The dynamic interactions between the tumor cells and the stroma may promote tumor progression and metastasis and dictate resistance to established cancer therapies. Therefore, novel antitumor approaches should combine anticancer and anti-stroma strategies targeting dysregulated tumor extracellular matrix (ECM). ECM remodeling is a hallmark of solid tumors, leading to extensive biochemical and biomechanical changes, affecting cell signaling and tumor tissue three-dimensional architecture. Increased deposition of fibrillar collagen is the most distinctive alteration of the tumor ECM. Consequently, several anticancer therapeutic strategies have been developed to reduce excessive tumor collagen deposition.
  • 513
  • 17 Oct 2022
Topic Review
Glucocorticoid Receptor Activity
Glucocorticoids (GCs) represent a well-known class of lipophilic steroid hormones biosynthesised, with a circadian rhythm, by the adrenal glands in humans and by the inter-renal tissue in teleost fish (e.g., zebrafish).
  • 512
  • 23 Dec 2021
Topic Review
Immunomodulatory Properties of Bioactive Products
Bioactive products have an effect on the molecular and biochemical functions of a living organism, causing a physiological response of the given tissue. Such a products are biologically active. Depending on the active component and amount, the effects of such products can be positive or negative. Bioactive products can be food ingredients or dietary supplements, and while they are not required for survival, they are responsible for changes in the body’s health.
  • 512
  • 24 Mar 2022
Topic Review
The Tumor Heterogeneity in Sézary Syndrome
Sézary syndrome (SS) is an aggressive variant of cutaneous t-cell lymphoma characterized by the accumulation of neoplastic CD4+ lymphocytes—the SS cells—mainly in blood, lymph nodes, and skin. The tumor spread pattern of SS makes this lymphoma a unique model of disease that allows a concurrent blood and skin sampling for analysis.
  • 512
  • 28 Jun 2022
Topic Review
Chimeric Antigen Receptor T-Cell Therapy
The treatment landscape for hematologic malignancies has changed since the recent approval of highly effective CAR-T. Chimeric antigen receptor T-cell therapy (CAR-T) is a type of immunotherapy in which a patient’s T cells are collected and genetically engineered to improve their ability to recognize and kill cancer cells. However, several issues are still unsolved and represent the challenges for the coming years. The lack of initial responses and early relapse are some hurdles to be tackled. Moreover, new strategies are needed to increase the safety profile or shorten the manufacturing process during CAR-T cells therapy production. Finally, the clinical experience with CAR-T cells for solid tumors has been less encouraging, and development in this setting is desirable.
  • 512
  • 23 Nov 2022
Topic Review
The Immunomodulatory Effects of Statins on Macrophages
Statins are 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors used worldwide to manage dyslipidaemia and thus limit the development of atherosclerotic disease and its complications. These atheroprotective drugs are now known to exert pleiotropic actions outside of their cholesterol-lowering activity, including altering immune cell function. Macrophages are phagocytic leukocytes that play critical functional roles in the pathogenesis of atherosclerosis and are directly targeted by statins. Early studies documented the anti-inflammatory effects of statins on macrophages, but emerging evidence suggests that these drugs can also enhance pro-inflammatory macrophage responses, creating an unresolved paradox. 
  • 508
  • 08 Jun 2022
Topic Review
Extracellular Traps in Disease/Protection
The first formal description of the microbicidal activity of extracellular traps (ETs) containing DNA occurred in neutrophils in 2004. Since then, ETs have been identified in different populations of cells involved in both innate and adaptive immune responses. Much of the knowledge has been obtained from in vitro or ex vivo studies; however, in vivo evaluations in experimental models and human biological materials have corroborated some of the results obtained. Two types of ETs have been described—suicidal and vital ETs, with or without the death of the producer cell. The studies showed that the same cell type may have more than one ETs formation mechanism and that different cells may have similar ETs formation mechanisms. ETs can act by controlling or promoting the mechanisms involved in the development and evolution of various infectious and non-infectious diseases, such as autoimmune, cardiovascular, thrombotic, and neoplastic diseases, among others.
  • 507
  • 09 Aug 2021
Topic Review
TMDC Nanozymes: Application Perspective
Applications of TMDC NZs in different fields—starting from biosensing to different treatment fields like antibacterial, anti-inflammation activity and cancer therapy—are discussed in more details. 
  • 507
  • 29 Mar 2022
Topic Review
Species of Gut Bacteria Associated with Antitumor Immunity
Both preclinical and clinical studies have demonstrated that the modulation of gut microbiota could be a promising strategy for enhancing antitumor immune responses and reducing resistance to immunotherapy in cancer. Various mechanisms, including activation of pattern recognition receptors, gut commensals-produced metabolites and antigen mimicry, have been revealed. Different gut microbiota modulation strategies have been raised, such as fecal microbiota transplantation, probiotics, and dietary selection.
  • 507
  • 02 Dec 2022
Topic Review
Chasing Uterine Cancer with NK Cell-Based Immunotherapies
Gynecological cancers, including endometrial adenocarcinoma, significantly contribute to cancer incidence and mortality worldwide. The immune system plays a significant role in endometrial cancer pathogenesis. (uterine) NK cells, a component of innate immunity, are among the critical innate immune cells in the uterus crucial in menstruation, embryonic development, and fighting infections. NK cell number and function influence endometrial cancer development and progression. Hence, it becomes crucial to understand the role of local (uterine) NK cells in uterine cancer.
  • 507
  • 20 Feb 2023
  • Page
  • of
  • 39
ScholarVision Creations